Latest filing published 20 Aug 2024 for Altimmune, Inc., €49k. Read the official filing
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
David Drutz is a declared insider of Altimmune, Inc. (board member), with filings sourced from SEC (Form 4). The record holds 12 filings, for trades running from 19 November 2021 to 19 August 2024.
Market trades split into 4 purchases (€49k) and 2 sales (€100k). The net balance comes to €51k on the selling side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 6 option exercises. In 2024 alone, the filings show no purchases and 2 sales.
Half of the purchases are above €6,340 and half below. Clusters matter here: 1 out of 4 purchases overlapped with buying by a colleague within 30 days. Purchases made close together by different insiders form what is called a cluster.
Most recently, on 20 August 2024, the filings show an open-market sale worth €49k in Altimmune, Inc. The last purchase on record was published on 15 August 2023, which is 1,160 days ago. The median gap between a trade and its publication by SEC (Form 4) is 1 day. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations